The U.S. Food and Drug Administration (FDA) recently announced that AndroGel manufacturers would be required to add heart attack and stroke risks to the drug’s warning label, but AndroGel lawsuits are already underway.
Lawyers began filing testosterone lawsuits last year on behalf of men who suffered a heart attack or stroke while taking prescription testosterone. There are 14 manufacturers in the two-billion-dollar market. In June 2014, a centralized Testosterone multidistrict litigation (MDL) was established in Chicago so that testosterone lawsuits involving all 14 manufactures could be filed in one place.
The FDA’s March 3rd safety communication instructs all testosterone manufactures to update their warning label to include heart attack and stroke risks and to clearly state the correct use for which Low T drugs were approved.
More than two million men are taking prescription testosterone drugs, Good Morning America reported. However, the majority of these men are taking the drug for a use in which it was not approved.
AndroGel was approved to treat low testosterone caused by a serious medical condition, but the majority of men taking testosterone are using it to treat Low T caused by aging, according to a September 2014 New York Times article. Manufactures are now required to make it clear that testosterone is not approved to treat symptoms of aging.
If you or a loved one suffered a heart attack or stroke while using AndroGel, you may be eligible for compensation. Contact a testosterone lawyer to find out if you qualify.